Lars Steinstraesser
Overview
Explore the profile of Lars Steinstraesser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1878
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Tilkorn D, Daigeler A, Hauser J, Ring A, Stricker I, Schmitz I, et al.
J Cancer Res Clin Oncol
. 2012 Feb;
138(5):877-84.
PMID: 22311184
Purpose: Preclinical development of antisarcoma therapy is primarily based on the subcutaneous transplantation of sarcoma xenografts. Tumour cell survival remains a hurdle of current models, which has been attributed to...
22.
Tilkorn D, Daigeler A, Stricker I, Schaffran A, Schmitz I, Steinstraesser L, et al.
Anticancer Res
. 2011 Dec;
31(12):4061-6.
PMID: 22199262
Background: There are no xenograft models of low-grade soft tissue sarcoma. Transplant survival remains an obstacle in sarcoma xenograft models and is attributed to post-transplantation hypoxia. Models with an intrinsic...
23.
Al-Benna S, Shai Y, Jacobsen F, Steinstraesser L
Int J Mol Sci
. 2011 Dec;
12(11):8027-51.
PMID: 22174648
Cancer continues to be a leading source of morbidity and mortality worldwide in spite of progress in oncolytic therapies. In addition, the incidence of cancers affecting the breast, kidney, prostate...
24.
Steinstraesser L, Flak E, Witte B, Ring A, Tilkorn D, Hauser J, et al.
Plast Reconstr Surg
. 2011 Sep;
128(4):306e-313e.
PMID: 21921743
Background: Published trials evaluating pressure garment and/or silicone therapy as a treatment for hypertrophic burn scarring are of poor quality and highly susceptible to bias. The authors' aim was to...
25.
Steinstraesser L, Hauk J, Al-Benna S, Langer S, Ring A, Kesting M, et al.
Drug Chem Toxicol
. 2011 Aug;
35(1):96-103.
PMID: 21851146
Soft tissue sarcomas (STSs) are a heterogeneous group of rare, mesenchymal tumors. Treatment with common chemotherapeutic drugs is consistently associated with low response rates and high rates of adverse toxic...
26.
Jacobsen F, Rittig A, Steinstraesser L
Burns
. 2011 Aug;
37(7):1268-9.
PMID: 21839584
No abstract available.
27.
Steinstraesser L, Trust G, Rittig A, Hirsch T, Kesting M, Steinau H, et al.
Plast Reconstr Surg
. 2011 May;
127(5):1838-1846.
PMID: 21532413
Background: Wound infections caused by multidrug-resistant bacteria are a major issue in wound care. An occlusive dressing delivering an antimicrobial agent to the wound may be advantageous. The objective of...
28.
Steinstraesser L, Agarwal R, Stricker I, Steinau H, Al-Benna S
Case Rep Oncol
. 2011 Apr;
4(1):222-8.
PMID: 21516237
Synovial sarcoma is a rare type of soft tissue sarcoma that occurs mostly in young adults, and it is always regarded as a high-grade tumor. Here, we report the case...
29.
Steinstraesser L, Hauk J, Schubert C, Al-Benna S, Stricker I, Hatt H, et al.
PLoS One
. 2011 Apr;
6(3):e18321.
PMID: 21483840
Background: Soft tissue sarcoma (STS) is an anatomically and histologically heterogeneous neoplasia that shares a putative mesenchymal cell origin. The treatment with common chemotherapeutics is still unsatisfying because of association...
30.
Steinstraesser L, Hauk J, Jacobsen F, Stricker I, Steinau H, Al-Benna S
In Vivo
. 2011 Apr;
25(2):165-9.
PMID: 21471530
Background: Synovial sarcoma represents one of the most frequent malignant tumours of soft tissues. Its prognosis is poor because of chemoresistance and high metastatic potential. Improvement of synovial sarcoma outcome...